在患有COPD的个体中,20米6分钟步行测试的最小重要差异
Suelen R Klein1, Anelise B Munari1, Manuela Karloh2
1Núcleo de Assistência, Ensino e Pesquisa em Reabilitação Pulmonar, Universidade do Estado de Santa Catarina, Florianópolis, Santa Catarina, Brazil; and Graduate Program in Human Movement Sciences, Center for Health and Sports Sciences, University of Santa Catarina, Florianópolis, Santa Catarina, Brazil.
20米6分钟步行测试 (6MWT20) 有效地测量了COPD患者的功能能力. 这项研究确定了其对肺部康复的反应能力和20米的最小重要差异 (MID).
科学领域:
- 肺部医学 肺部医学
- 康复科学 康复科学 康复科学
- 临床评估 临床评估
背景情况:
- 20米6分钟步行测试 (6MWT20) 是评估功能能力的验证工具.
- 它的反应能力和COPD人群中最小重要的差异 (MID) 需要研究.
研究的目的:
- 评估6MWT20在患有慢性阻塞性肺病 (COPD) 的个体中的响应能力.
- 在这个患者群体中确定6MWT20的最小重要差异 (MID).
主要方法:
- 53名COPD患者接受了评估,包括肺功能,日常生活活动 (ADL),呼吸障碍和健康状况.
- 6MWT20是主要的结果指标,评估了对肺部康复 (PR) 的反应能力.
- 使用接收器操作特征 (ROC) 曲线分析来确定MID.
主要成果:
- 6MWT20对PR表现出显著的反应性,平均改善39m (P < .001) 和大效果大小 (1.07).
- 在PR后的学习效应是最小的 (1.45%),测试重复测试的可靠性很高 (ICC = 0.99).
- 对于6MWT20来说,ROC分析确定了20米的距离为MID,得到了其他患者报告的结果措施的MID的支持.
结论:
- 20米6分钟步行测试 (6MWT20) 是对接受肺部康复的COPD患者功能能力的响应性测量.
- 在这个群体中,为6MWT20建立了20米的最小重要差异 (MID).
更多相关视频
08:44Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
Published on: February 2, 2024
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
相关概念视频
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Management Using Bronchodilators and Corticosteroids
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
